ARS Pharmaceuticals(SPRY) Stock Price Today

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

ARS Pharmaceuticals: Strategic Growth and Market Penetration Justify Buy Rating
TipRanksMar 24 20:35 ET · Ratings
Raymond James Maintains ARS Pharmaceuticals(SPRY.US) With Buy Rating, Raises Target Price to $32
Moomoo NewsMar 24 13:31 ET · Ratings
Scotiabank Maintains ARS Pharmaceuticals(SPRY.US) With Buy Rating, Maintains Target Price $30
Moomoo NewsMar 22 13:32 ET · Ratings
ARS Pharmaceuticals' Earnings Call Highlights Growth and Challenges
TipRanksMar 21 20:20 ET
Insider Sale: Chief Commercial Officer of $SPRY Sells 10,000 Shares
Quiver QuantitativeMar 21 18:46 ET
ARS Pharmaceuticals, Inc.'s (NASDAQ:SPRY) Popularity With Investors Is Under Threat From Overpricing
Simply Wall StMar 21 09:23 ET

Comments

Benjamin Franklin 76

Mar 18 04:20

Upcoming Earnings!

$ARS Pharmaceuticals (SPRY.US)$
ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) is a biopharmaceutical company focused on developing and commercializing neffy, a needle-free intranasal epinephrine spray designed for emergency treatment of Type I allergic reactions, including anaphylaxis. Below is an analysis of SPRY stock based on available data as of March 17, 2025:
### Company Overview
- Product: Neffy is the first FDA-approved needle-free epinephrine delivery system, offering an al...

6

1

Jaguar8

Mar 6 09:01

🟡Watchlist, MARCH 6,2025, Thursday. NFA - DrJag8

NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If y...

34

7

Trytosaveabit

Mar 6 05:11

news

$ARS Pharmaceuticals (SPRY.US)$ Reuters
just
ARS Pharmaceuticals Announces FDA Approval of Neffy® 1 Mg (Epinephrine Nasal Spray) for Type I Allergic Reactions, Including Anaphylaxis, in Pediatric Patients Weighing 15 to

5

This_Guy

Dec 20, 2024 06:31

$ARS Pharmaceuticals (SPRY.US)$
ARS Pharmaceuticals Announces neffy® (Epinephrine Nasal Spray) is available on Express Scripts Commercial National Formularies
Positive
First FDA-approved needle-free epinephrine nasal spray
Rapid inclusion on Express Scripts Commercial National Formularies (9 weeks post-launch)
Access to millions of commercially insured patients
Superior product features: 30-month shelf-life, high temperature tolerance (122°F)
Negative
to patients weighing ≥30 kg (66 lbs.)
Current...

1